Edition:
United States

Baxter International Inc (BAX)

BAX on New York Consolidated

47.06USD
24 Aug 2016
Change (% chg)

-- (--)
Prev Close
$47.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,246,501
52-wk High
$49.49
52-wk Low
$32.18

Select another date:

Wed, Aug 10 2016

Fitch Rates Baxter International Inc.'s Notes Offering 'BBB+'

(The following statement was released by the rating agency) CHICAGO, August 10 (Fitch) Fitch Ratings has assigned a 'BBB+' rating to Baxter International Inc.'s (Baxter) senior unsecured notes offering. Fitch expects the net proceeds from the issuance to be used to pay down existing debt and short-term borrowings, as well as other general corporate purposes. Baxter had approximately $3.2 billion in outstanding debt at June 30, 2016. A full list of Baxter's ratings follows at the end of this

BRIEF-Sunshine Heart buys Baxter's Aquadex product line

* Sunshine Heart announces strategic acquisition of Aquadex product line from Baxter and a new credit facility with Silicon Valley Bank

BRIEF-Baxter presents results of study related to REVACLEAR dialyzer

* Baxter presents new evidence demonstrating REVACLEAR Dialyzer associated with lower drug use during hemodialysis

BRIEF-Baxter Q2 earnings $2.19/shr from cont ops

July 26 Baxter Reports Second Quarter 2016 Results And Raises Financial Outlook For Full

BRIEF-Baxter International sets quarterly dividend of $0.13 per share

* Sets quarterly dividend of $0.13 per share Source text for Eikon: Further company coverage:

BRIEF-Co Don says Bauerfeind AG is new major shareholder

* Bauerfeind AG indirectly holds a blocking minority of 25 pct of the shares in Co.Don AG Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Baxter International announces health canada approval of AMIA automated peritoneal dialysis system

* Baxter international says announces health canada approval of AMIA automated peritoneal dialysis system with sharesource connectivity platform

BRIEF-Baxter International reports data results from infusion system

* Data shows sigma spectrum infusion system users achieved 97 percent drug library compliance rate within the first month of implementation1 Source text for Eikon: Further company coverage:

BRIEF-Baxter International announces final exchange ratio of 1.1591 for Baxalta exchange offer

* Baxter announces final exchange ratio of 1.1591 for baxalta exchange offer

BRIEF-Co Don establishes scientific advisory board

* Establishes scientific advisory board Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: